University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ...

If you've ever taken an at-home diagnostic test for COVID-19, you can partially credit the technology to the Johns Hopkins University Center for Innovative Diagnostics for Infectious Diseases (CIDID).

OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company specializing in precision clinical diagnostics, has partnered with Regina Maria, Romania's leading private healthcare provider, ...

Car diagnostic tests scan a car’s components and integrated systems for errors or malfunctions before they become dangerous. These tests leverage computerization to keep your car in optimal working ...

Known as a host-response diagnostic, the cartridge-based blood test and Myrna instrument platform scans for about 30 genetic biomarkers that are activated by the body’s immune system as it ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

This simplified classification would make patient management and surveillance easier 4. There is a need for specific, inexpensive dengue diagnostic tests that can be used for clinical management ...

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

Now, on the heels of the study, the start-up plans to launch its test in the US market this quarter in collaboration with DiaCarta, a US-based precision diagnostics company, through its laboratory ...

Fourth Quarter Revenue: $2.62 billion, up 14.5% year-over-year. Organic Revenue Growth: 4.8% in the fourth quarter. Diagnostic Information Services Revenue Growth: 15.1% year-over-year.

The new biomarker tests will be incorporated into the AVISE® CTD platform, a diagnostic tool widely used to evaluate autoimmune diseases, this month. The new lupus assay, called the T-Cell Lupus ...

OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...